Concurrently, Moody’s affirmed its “A2” rating on the health system’s $370 million outstanding debt.
The assignment and affirmation are due to WakeMed’s strong market position, solid cash flow margins and good days cash on hand. Moody’s, however, expects the health system to remain leveraged.
The outlook is stable.
More articles on healthcare finance:
State-by-state breakdown of 102 rural hospital closures
10 hospitals seeking CFOs
How New York’s ‘baseball-style’ arbitration process reduced surprise bills: 7 notes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
